Overview

Pilot Study of Physostigmine-Enhanced Opioid Analgesia

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that the administration of physostigmine in the postoperative period after nephrectomy reduces opioid consumption.
Phase:
Phase 3
Details
Lead Sponsor:
Medical University of Graz
Treatments:
Physostigmine